GSK is redesigning pharmaceutical research around AI, from data infrastructure to autonomous scientific agents. Its platforms ...

GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk: London, UK Tuesday, May 19, 2026, 12:00 Hrs [IST] GSK plc announced tha ...

GSK has signed a new three-year agreement with Protas that aims to streamline trials across several core therapeutic areas.

Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight The pulmonary arterial hypertension clinical trial ...

Analysts at Citi have reiterated a 'buy' rating on AstraZeneca and a 'neutral' on GSK following the European pharma sector's first-quarter earnings season.

Patients with severe asthma who are typically underrepresented in clinical studies experienced improved outcomes with ...

GSK has disclosed a series of routine share dealings by senior executives under its Share Reward Plan, with ordinary shares acquired on 12 May 2026 on the London Stock Exchange. Participants include ...

Advertisers keep counting on Julie Bowen and Ty Burrell to reach out from "Modern Family" to yours. The duo, currently ...

President Donald Trump’s drug-pricing platform TrumpRx is expanding to offer 600 generic medications — and partner with ...

Cohere, the world’s leading sovereign AI company, announced today the acquisition of Reliant AI, a leading biopharma AI company with operations in Montreal and Berlin. This acquisition brings Reliant ...

New Drug Application (NDA) for tebipenem HBr for complicated urinary tract infections (cUTI), including pyelonephritis, is under review at the ...

New oncology approvals and specialty medicines begin contributing more as traditional portfolios face slower growth ...